BIOMAT Database Logo BIOMAT Database Logo

Anti-tumour necrosis factor alpha therapy in patients with impaired renal function. 2007

Axel J Hueber, and Andac Tunc, and Georg Schett, and Bernhard Manger

UI MeSH Term Description Entries
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

Axel J Hueber, and Andac Tunc, and Georg Schett, and Bernhard Manger
Optic neuritis occurring with anti-tumour necrosis factor alpha therapy.
September 2007, Annals of the rheumatic diseases,
Axel J Hueber, and Andac Tunc, and Georg Schett, and Bernhard Manger
Acute psychosis in three patients receiving anti-tumour necrosis factor-alpha therapy.
August 2008, Rheumatology (Oxford, England),
Axel J Hueber, and Andac Tunc, and Georg Schett, and Bernhard Manger
Acute renal failure in patient treated with anti-tumour necrosis factor alpha.
January 2011, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia,
Axel J Hueber, and Andac Tunc, and Georg Schett, and Bernhard Manger
Anti-tumour necrosis factor alpha therapy modulates ghrelin in patients with severe rheumatoid arthritis.
November 2008, Annals of the rheumatic diseases,
Axel J Hueber, and Andac Tunc, and Georg Schett, and Bernhard Manger
Anti-tumour necrosis factor-alpha therapy over conventional therapy improves endothelial function in adults with rheumatoid arthritis.
October 2006, Rheumatology international,
Axel J Hueber, and Andac Tunc, and Georg Schett, and Bernhard Manger
Anti-tumour necrosis factor (TNF)-alpha therapy in undifferentiated spondyloarthropathy.
January 2002, Clinical and experimental rheumatology,
Axel J Hueber, and Andac Tunc, and Georg Schett, and Bernhard Manger
Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-alpha therapy.
April 2007, Rheumatology (Oxford, England),
Axel J Hueber, and Andac Tunc, and Georg Schett, and Bernhard Manger
Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-alpha therapy.
September 2007, Rheumatology (Oxford, England),
Axel J Hueber, and Andac Tunc, and Georg Schett, and Bernhard Manger
Anti-tumour necrosis factor alpha therapy: can we afford it?
July 2005, Annals of the rheumatic diseases,
Axel J Hueber, and Andac Tunc, and Georg Schett, and Bernhard Manger
Asthenoazoospermia in patients receiving anti-tumour necrosis factor {alpha} agents.
November 2005, Annals of the rheumatic diseases,
Copied contents to your clipboard!